Stay updated on GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.

Latest updates to the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedNew help and navigation sections were added, including 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' label was standardized and the footer revision text updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new release of the page. No substantive content changes are indicated by this update.SummaryDifference0.0%

- Check35 days agoChange DetectedThe sponsor on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, updating the record to reflect the current sponsor responsible for the trial.SummaryDifference0.2%

- Check42 days agoChange DetectedThe revision tag in the page footer was updated from v3.5.3 to v3.5.4, signaling a minor version update of the platform. This change does not modify the displayed study information or navigation.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page’s footer/site build has been updated from Revision v3.5.2 to v3.5.3, reflecting a website release rather than any change to the clinical trial information.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2. This appears to be a metadata update rather than a substantive change to the study content.SummaryDifference0.0%

Stay in the know with updates to GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 Doses Study in Adult Cystic Fibrosis Clinical Trial page.